Ellie Krasney
About Ellie Krasney
Ellie Krasney is the Senior Director of Analytical Operations at BridgeBio, bringing extensive experience from her previous roles at Pfizer and Akebia Therapeutics. She holds a Master of Science in Chemistry from Vanderbilt University and has a strong background in analytical method development and regulatory compliance.
Work at BridgeBio
Ellie Krasney currently serves as Senior Director of Analytical Operations at BridgeBio, a position she has held since 2022. In this role, she oversees the development and validation of analytical methods, ensuring compliance with industry standards. She plays a crucial part in managing third-party development of analytical methods and stability assessments, contributing to the overall control strategy for drug substance and product filings throughout various stages of development.
Previous Experience at Pfizer
Ellie Krasney has extensive experience with Pfizer, where she worked for over a decade in various roles. Her positions included Senior Analytical Account Coordinator, Principal Scientist, Senior Principal Scientist, and Associate Research Fellow. During her tenure from 2000 to 2019, she focused on analytical sciences, contributing to method development and validation, as well as investigations into Out-of-Specification and Out-of-Trend results.
Educational Background
Ellie Krasney studied at Vanderbilt University, where she earned a Master of Science in Chemistry. She also completed her undergraduate studies at the University of Virginia, obtaining a Bachelor of Arts in Chemistry. Her educational background has provided her with a strong foundation in analytical techniques and methodologies relevant to her career in the pharmaceutical industry.
Experience in Analytical Sciences
Krasney has a diverse background in analytical sciences, having worked in various capacities across multiple organizations. Prior to her current role, she served as Director of Analytical Sciences at Akebia Therapeutics from 2019 to 2022. Her expertise includes a wide range of analytical techniques such as DSC, GC, HPLC, and LC/MS, which she applies in her project portfolio to support drug development and regulatory filings.
Medical Writing Expertise
Ellie Krasney has extensive experience in medical writing, particularly in the GLP and GMP environments. She focuses on Chemistry, Manufacturing, and Controls (CMC) sections of Investigational New Drug (IND) and FDA filings. Her ability to communicate complex scientific results through oral and written reports is a key aspect of her role, facilitating collaboration across teams and ensuring compliance with regulatory requirements.